Evidence map›Paper›PMID 40595975›Full record

ArticleScientific reports2025

Multi-omics analysis of diabetic cardiomyopathy pathogenesis using a type 2 diabetic Zucker diabetic fatty rat model.

Kazuhiro Tanabe, Qianqian Zheng, Xuguang Zhang, Naoki Tanaka, Chihiro Hayashi, Asaka Yokota, Rina Otsuka, Tomoko Katahira, Motoyuki Kohjima, Makoto Nakamuta

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Carnosine-Related Metabolism in Rat Cardiomyocytes and Human Heart Tissue.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kazuhiro TanabeMedical Solution Promotion Department, Medical Solution Segment, LSI Medience Corporation, 3-30-1, Shimura, Itabashi, Tokyo, 174-8555, Japan. kazuhirotanabe77@gmail.com.
Qianqian ZhengDepartment of Metabolic Regulation, Shinshu University School of Medicine, Matsumoto, Japan.
Xuguang ZhangDepartment of Metabolic Regulation, Shinshu University School of Medicine, Matsumoto, Japan.
Naoki TanakaDepartment of Global Medical Research Promotion, Shinshu University Graduate School of Medicine, Matsumoto, Japan.
Chihiro HayashiMedical Solution Promotion Department, Medical Solution Segment, LSI Medience Corporation, 3-30-1, Shimura, Itabashi, Tokyo, 174-8555, Japan.
Asaka YokotaMedical Solution Promotion Department, Medical Solution Segment, LSI Medience Corporation, 3-30-1, Shimura, Itabashi, Tokyo, 174-8555, Japan.
Rina OtsukaMedical Solution Promotion Department, Medical Solution Segment, LSI Medience Corporation, 3-30-1, Shimura, Itabashi, Tokyo, 174-8555, Japan.
Tomoko KatahiraMedical Solution Promotion Department, Medical Solution Segment, LSI Medience Corporation, 3-30-1, Shimura, Itabashi, Tokyo, 174-8555, Japan.
Motoyuki KohjimaDepartment of Gastroenterology, NHO Kyushu Medical Center, Fukuoka, Japan.
Makoto NakamutaDepartment of Gastroenterology, NHO Kyushu Medical Center, Fukuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic cardiomyopathy (DCM) is a leading cause of mortality in patients with diabetes, highlighting the need to better understand its mechanisms for effective treatment. The primary pathogenic mechanism of DCM is mitochondrial dysfunction associated with increased oxidative stress; however, the exact reasons why diabetes triggers this condition remain unclear. An 8-week-old male Zucker diabetic fatty rat model of type 2 diabetes was used for this analysis. Metabolomic and lipidomic analyses were conducted not only in the heart but also across several other organs to elucidate metabolic changes specifically occurring in the heart. Proteomic analysis and gene expression profiling using qPCR were performed on the heart to achieve a comprehensive understanding. The marked reduction of the radical scavenger carnosine and the increased gene expression of catalase and Sestrin2 in the heart suggested elevated oxidative stress. A decrease in Complex I proteins and an increase in Complex I gene expression indicate rapid mitochondrial turnover in diabetic cardiomyocytes. Additionally, the increased expression of adenylate kinase and xanthine oxidoreductase accelerated the adenosine monophosphate degradation pathway, leading to reactive oxygen species generation. These insights into mitochondrial dysfunction and metabolic disturbances could inform the development of innovative therapies and pharmacological approaches for managing diabetic heart failure.

Indexed as

Diabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Diabetic CardiomyopathiesAnimalsDisease Models, AnimalGene Expression ProfilingMaleMetabolomicsMultiomicsMyocardiumMyocytes, CardiacOxidative StressProteomicsRatsRats, ZuckerReactive Oxygen SpeciesReactive Oxygen SpeciesDiabetic cardiomyopathyMetabolomicsMitochondrial disfunctionOxidative stressProteomicsROS

Identifiers

PMID40595975
PMCPMC12215485

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.